Long-Term Assets: The sum of all assets classified as non-current.
Alto Neuroscience, Inc. (ANRO) had Long-Term Assets of $8.03M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-17.71M |
|
-- |
|
-- |
|
$18.68M |
|
$-18.68M |
|
$0.98M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-18.68M |
|
$-18.51M |
|
27.07M |
|
27.07M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$149.85M |
|
$2.31M |
|
|
Long-Term Assets |
$8.03M |
$157.88M |
|
$8.13M |
|
$22.12M |
|
$26.34M |
|
$34.47M |
|
$123.41M |
|
$123.41M |
|
$123.41M |
|
27.07M |
|
| Cash Flow Statement Financials | |
$-30.34M |
|
$-0.02M |
|
$9.74M |
|
$168.73M |
|
$148.09M |
|
$-20.64M |
|
$3.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.43 |
|
-- |
|
-- |
|
0.15 |
|
0.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.35% |
|
-14.35% |
|
-11.22% |
|
-12.17% |
|
$4.56 |
|
$-1.12 |
|
$-1.12 |
|